MAUDE(MAUDE)
MAUDE is used to support defensible premarket and postmarket device decisions.
Usage Examples
- MAUDE was incorporated into postmarket monitoring and complaint trending.
- MAUDE was addressed in the device submission to support pathway alignment.
- The team used MAUDE during design review and verification planning.
What is MAUDE?
MAUDE is used in regulated product development to connect strategy, execution, and documentation quality. Device teams rely on it for evidence generation, pathway execution, and postmarket surveillance control.
Regulatory Context
This term appears most often in medical devices workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside FDA, ICH.
When This Matters
- MAUDE was incorporated into postmarket monitoring and complaint trending.
- MAUDE was addressed in the device submission to support pathway alignment.
- The team used MAUDE during design review and verification planning.
Common Mistakes
- Using drug-only submission assumptions for device regulatory pathways.
- Ignoring post-market obligations in pre-market planning.
- Weak predicate and classification rationale in dossier narratives.
Related Regulations
Frequently Asked Questions
MAUDE is a regulatory concept used to improve submission quality, compliance consistency, and decision traceability.
MAUDE helps align design, risk, and evidence packages with reviewer expectations.
Weak execution of MAUDE often leads to avoidable deficiencies, rework, and slower authority review cycles.
Related Terms
Related Use Cases
Prepare 510(k), PMA, and De Novo submissions with AI-guided pathway selection
Manage 15+ client programs from one dashboard with per-client workspaces and tracking
Cut regulatory intelligence tracking from 10+ hours/week to automated, real-time alerts
Track GxP regulation changes and enforcement trends
Related Regulatory Intelligence
Related Actions
Sources & References
